Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving live birth rates after ICSI with Peptide Fertiline supplementation
2020-004214-35Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of gonadorelin in infertility (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Live birth rate after first embryo transfer. Started Jan 2021; status: active.
02
Drugs
gonadorelin
03
Conditions
infertility
Beyond the preview
Go deeper on 2020-004214-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004214-35.